The cerebral blood flow (CBF) is an important vital parameter in neurointensive care. Currently, there is no non-invasive method for its measurement that can easily be applied at the bedside. A new tool to determine CBF is based on near-infrared spectroscopy (NIRS) applied together with indocyanine green (ICG) dye dilution. From a bilateral measurement on selected regions on the head of infrared (IR) absorption at various wavelengths during the dilution maneuver, the vascular perfusion characteristics of the two brain hemispheres can be determined in terms of mean transit time (mtt) of ICG, cerebral blood volume (CBV) and CBF. So far, on nine healthy volunteers, NIRS ICG dye dilution bihemispheric measurements were performed, which yielded to mtt given as median (range) of 9.3 s (5.1-16.3 s), CBV of 3.5 ml/100 g (1.7-4.1 ml/100 g), and CBF of 18.2 ml/(100 g×min) [11.1-48.6 
Introduction
The importance of monitoring cerebral perfusion and oxygenation in patients suffering from stroke and severe brain injury in neurointensive care is well accepted [1, 2] . However, the search for an easy, safe and reliable method to measure cerebral blood flow (CBF) with high resolution rapidly and repeatedly at the bedside in the intensive care unit (ICU) is still a matter of investigation. Despite its limitations, near-infrared spectroscopy (NIRS) is seen as a convenient tool [3] .
In 1977, Jöbsis established NIRS as a non-invasive method to detect changes in oxygenated (oxy-Hb) and deoxygenated (deoxy-Hb) haemoglobin in the head. In 1988, Edwards [4] used NIRS to determine CBF using the Fick principle and oxyhemoglobin as tracer. Results from studies on newborn infants were in accordance with the results of established methods like PET, while for animal experiments and adult human studies, the results showed a high variability and poor agreement with results of reference methods [5] .
Since 1993, indocyanine green (ICG) dye, a strong near-infrared absorber, has been used to determine CBV and CBF [6] [7] [8] . The dye ICG itself has been approved by the United States Food and Drug Administration and is often used for medical diagnosis [9] [10] [11] [12] . An advantage of ICG is the presence of an absorption maximum near the isobestic point at a wavelength of 805 nm, where oxy-Hb and deoxy-Hb show the same absorption characteristics. ICG binds to plasma proteins, has a low toxicity, and is rapidly excreted by the liver, almost exclusively into the bile [9, 13, 14] .
In 1998, Kuebler [15] used the NIRS data to calculate the blood flow index (BFI). Blood flow index (BFI) was defined as the coefficient between maximum ICG signal obtained by NIRS and the rise time. The rise time is the time interval between 10% and 90% of the maximum signal during ICG inflow [15] . According to Bland & Altman, the consistency of BFI values as a relative measure of regional CBF with CBF values obtained with the established and validated microsphere technique was unsatisfactory for piglets. Although the BFI is simple to determine, it is a relative measure of the blood flow only which can be used to detect changes in the CBF within an individual [16] .
In 2003, Keller performed a validation study, where NIRS ICG dye dilution CBF measurements were compared with corresponding values obtained from perfusion-weighted magnetic resonance imaging (MRI) measurements. The study in healthy volunteers showed that absolute values and changes in CBF were in agreement with values obtained by perfusion-weighted MRI. Furthermore, an algorithm was presented to extract mean transit time (mtt), cerebral blood volume (CBV), and CBF from the dye dilution slopes of ICG within the optically interrogated segments. Because of an insufficient sampling rate and partly low ICG concentrations, however, the arterial pulsatility was not always correctly detected which then impeded an evaluation.
The objectives of the present study were as follows, to optimize the NIRS ICG dye dilution technique for quantitative measurements of mtt, CBV, and CBF with a temporal resolution of 50 Hz.
To strengthen the OD signal quality, the measurements were performed with a body weight related dose of ICG instead of a fixed dose of 25 mg as in the previous study. Additionally, the current hematocrit (HKT) of the healthy volunteers was determined in the course of a blood gas analysis of venous blood. Algorithm to determine CBV [7] was based on the quotient of the calculated ICG concentration in the arterial inflow and the estimated ICG concentration in the tissue. After determination of mtt for ICG within the optically observed segment, the CBF within the region could be calculated.
To detect secondary ischemic events in neurocritical care patients, critical threshold values have to be identified. Therefore, the median values for mtt, CBV, and CBF were calculated in a study of bilateral NIRS ICG dye dilution measurements performed on 10 healthy volunteers. Additionally, BFI which is easier to be calculated was extracted and compared with CBF using a Bland & Altman plot.
In healthy volunteers, under physiological conditions, no sign of inter-individual differences between measurement values obtained over the both hemispheres may occur. To proof the stability of the optimized algorithm, an analysis was performed between results from the right and left hemispheres for CBF.
Material and methods

Subjects and experimental design
Bilateral NIRS ICG dye dilution measurements were performed on ten healthy volunteers in supine position (Ethics Committee of the University Zurich No. E-36/2004).
Ten volunteers (2 men and 8 women) had a mean age of 35.7 ±9.4 years and a mean weight of 65 ±15.2 kg. For each volunteer, a blood gas analysis was performed on venous blood sample to obtain the hematocrit. A flexible headband was fixed to the head with optodes arranged at the forehead (Fig. 1) . The inter-optode distance between emitter and receiver was d = 4.5 cm which was found to be optimal in an earlier study [17] . Before measurement, the intensity of the reflected light in the receiver optodes (R 1 and R 2 ) was recorded, and the gain and output signal level were adjusted to the individual subject.
After a baseline data collection (1 min), ICG dye (Pulsion GmbH, Germany) in a dose of 0.5 mg per kg body weight (dissolved in 10 mg/ml 5% glucose) was injected into a catheter inserted into an ante-cubital vein, followed by a 10 ml/mg injection of 5% glucose flush. Optical density (OD) signal collection continued for 5 minutes and the passage of the ICG bolus was in parallel monitored on both hemispheres of the fore brain.
During post-processing of the OD signals the mtt, CBV, and CBF were determined using the algorithm described in Sect. 2.3. Additionally, the BFI [15] (Sect. 2.4.) was extracted.
NIRS ICG dye dilution equipment
A continuous wave NIRS instrument (OxyMon, Artinis Medical Systems, The Netherlands) was used. The OxyMon contains separate units for two transmitters and two receivers. Each transmitter is equipped with the laser-diodes, while the two receiver units contain the photodiodes. Pulsed class IIIb lasers are temperature stabilized via Peltier elements and have a peak power of 20 W, a mean power of 1 mW, a repetition rate of 1 kHz, and work with a pulse-length of 50 µs. NIRS measurements were performed with wavelengths of 908 nm, 857 nm, and 782 nm, respectively. The wavelength for ICG has not been applied. Optodes were directly applied on the skin without further optical connections. The optical fibers are mixed bundles of 12800 graded index single fibers with a diameter of each 50 µm. The optical fiber bundle for the emitters are coming in three bundles from the three lasers and are then randomized on the side which is attached to the skin. Each optical fiber has a length of 1.8 m and a diameter of 4 mm with a numerical aperture of 0.66. While continuously switching between the three lasers, each pulsed laser applies the specific wavelength within a pulse of 50 µs.
Algorithm for mtt, CBV, and CB.
The NIRS ICG dye dilution method does not involve spectroscopy in the strict sense, but it is restricted to an intensity measurement of transmitted light at different wavelengths, whereby for each wavelength, the transmitted light has the same wavelength as the incident light. This implies for the chosen setup that the receivers R 1 and R 2 produce three signals corresponding to the three incident wavelengths, whereby the incident pulses are time-multiplexed and applied through the two emitters, as shown in the monitored dataset in Fig. 2 .
A distinction can be made between a baseline signal and a time varying component of the signal. The baseline signal, which for all practical purposes is constant in time, depends on the absorption coefficient á in (cm -1 ) of the tissue and is strongly dependent on the relative blood content of the involved tissues. The time dependent signal is caused by a number of effects, such as arterial pulsation, variation of blood oxygenation, the passage of a tracer, e.g., ICG or a short-term change of relative blood volume contained in the blood vessels in the various tissues along the photon paths.
Since the baseline is usually not of interest clinically, the time varying signal is extracted with the aid of a difference procedure such that the baseline drops out. This signal is normalized and denoted as the optical density signal (OD).
The high frequency component (AC high ) of the OD signals is caused by the heart beat and has a range of 0.5-1.5 Hz. To extract the heart rate, a high pass filter is applied.
The low frequency component (AC low ), is strongly dependent on the ICG transient (amplitude and transient time characteristics) in the observed volume. The frequency range of this signal is lower than the heart rate and is in the range of 0-0.5 Hz for a resting healthy volunteer.
The OD signals (Fig. 3) can be described mathematically using the modified Lambert-Beer equation [18] . This equation was adapted to the current case of the NIRS ICG dye dilution measurement, where the tracer ICG applied in the form of a bolus injection.
OD t
Here, I 0 is the baseline of the OD signal, while I(t) is the time dependent intensity signal. The absorption coefficients of the different tissues (skin, skull, and brain tissue) are denoted as á j , while c j stands for the concentration of these chromophores within the tissues, e.g., haemoglobin. Likewise, the absorption coefficient for ICG is given by á ICG and the concentration c ICG tissue is not a naturally occurring substance within the human body, thus the concentration of ICG at the point of the injection is 0. The mean concentrations of the other chromophores (including blood) within the tissue are assumed to be constant for the time of measurement (5 min), which corresponds also to the 1/e elimination time of ICG. Starting with the ICG injection, the deviation from the baseline signal due to the ICG passage becomes apparent. After normalization and subtraction, only the time varying component of the OD signal is further considered.
The differential path length factor (DPF) describes the relationship between the mean free path length of the photons and the geometrical distance between the emitter and receiver. A DPF = 5.9 is used within the algorithm, which corresponds to values shown in simulations [19] , while d a geometry-dependent factor and remains constant for the duration of the measurement [20] . The monitored and normalized OD signals including the passage of the tracer ICG are interpreted as regional transfer functions for the two optically interrogated regions within the two hemispheres of the cerebral blood system. Post-processing is made in three steps in order to determine the mtt of the ICG dye in the blood vessels in the optical segment, the CBV as well as the CBF, as shown in Fig. 4 . First, the mtt is determined by fitting the transfer function (described in Sect. 2.3.1 and in Appendix A) to the normalized curve. Second, the calculation of the ICG concentration within the illuminated tissue segments of the head (explained in Sect. 2.3.2) is performed and third, the ICG concentration in the arterial inflow (described in Sect. 2.3.3) is estimated. The latter two values are used to estimate the CBV within the illuminated tissue segments of the head. Finally, the calculated CBV values are used together with the mtts to determine CBF.
Determination of mtt
To determine the global mtt of the entire cerebral system, in a strict sense, invasive measurements would have to be made in the carotid artery and the internal jugular vein. Due to the high risk for the patient, this procedure was not applied. Instead, the limited volume of the illuminated area of the brain was used to determine the response function of the cerebral system, also denoted as the transport function g(u) [21] . It should thereby be noted that in case of pathologies, different areas of the brain may exhibit different transport characteristics. Our locally selective approach allows monitoring such important differences. A 'black box' approach [22] was applied to calculate the transport function where the passage of a tracer or indicator through an organ is described by a convolution integral. The detailed mathematical explanation is given in Appendix A.
Determination of ICG concentration in tissue
The low frequency component of the normalized OD signals was determined after filtering and removal of the variations caused by heart and respiration rates. So, Eq. (1) can be rewritten as
The ICG concentration in the tissue of the optically observed segment can be approximated as
To solve Eq. (3), the absorption coefficient of the ICG for the applied wavelength has to be known. Yet, since ICG binds to plasma proteins, this absorption coefficient is not constant; instead it depends on the concentration of ICG in plasma. As an approximation, based on the molar extinction coefficient of ICG in plasma with 65 µm by Landsman [23] the absorption coefficients have been determined for the three wavelength 782 nm, 857 nm, and 90 nm and kept constant for the post-processing. Apart from that, this equation cannot be solved in a straightforward fashion. With ICG as an intravascular indicator, a characteristic dye dilution curve, as described by Hoeft with a typically second peak reflecting recirculation can be registered [47] . Shortly after the very rapid injection of ICG, the distribution is not homogenous within the blood, instead the bolus is more or less staying as a bolus. This effect is characterized by the absorption peak visible in the OD signal slope in Fig. 3 . Only after the first recirculation, which takes, depending on cardiac output a time period of 20-35 s, intermixing is completed. Implying that the blood-bolus intermix coming from the head once passed the heart and has been intermixed with the upcoming blood from the body. A back--extrapolation function of the OD signal can be used to estimate the ideal ICG and blood intermixing, named Cdo, at the end of the calculated mtt. The result is used as a notional concentration of ICG at the moment of injection (for t = 0). This notional concentration replaces the difference OD(t) -OD(t 0 ) in Eq. (3).
Equation 4 was used to calculate the concentration of ICG in the tissue. It should be noted that this is only valid under the assumption that Eq. (1) can be applied, whereby the constant C, representing the scattering and absorption characteristics of the observed tissue, has not been changed by the ICG.
Determination of ICG concentration in blood
The determination of the ICG concentration in the arterial blood was based on the assumption that ICG is homogeneously distributed in the blood. The total blood volume (BV) of the patient, in turn, was calculated in relation to the body weight (BW) of the patient based on Documenta Geigy Scientific Tables [24] . Accordingly, the blood volume (BV BW ) for men is given by 70 ml/kg bodyweight (BW), respectively for women by 65 ml/kg bodyweight.
The absorption characteristics of ICG depend likewise on the solute as well as on the concentration therein [23] . Because of the plasma protein binding, the calculated BV BW has to be corrected according to the plasma component of the blood. Therefore, the haemoglobin concentration of the patient's blood is determined before the ICG injection. Typical values of the hematocrit (HKT) of healthy adults are for women in the range of 37-47%, with a mean of HKT female = 42%, while for men the range is 40-54%, with a mean HKT male = 47% [24] .
To determine the ICG concentration in arterial blood 
This procedure is justified due to the fact that ICG cannot pass the blood brain barrier [14] .
The cerebral blood flow CBF NIRS of the examined region, defined as the blood volume (BV) given in (ml) passing per (min) through the brain tissue volume (BV tissue ) in 100 g and derived from the NIRS measurement, then follows as
By this definition CBF NIRS is given in ml/(100 g×min).
Calculation of the blood flow index
Additionally, according to the method of Kuebler [15] between the points of 10% and 90% of the maximal signal during ICG inflow at the wavelength of 785 nm.
In a next step, the BFI results were correlated with the determined CBF results of the post-processed data of the NIRS ICG dye dilution measurement. Based on this correlation, the BFI results were transformed into cerebral blood flow values, as Kuebler [15] transformed the BFI values into cerebral blood flow values based on the correlation of the BFI values and CBF results of radioactive microsphere method for measurements on piglets.
Statistical analysis
Data are given as median and range values for the complete data set (n = 18) and as mean ±SD for the two hemispheres. For the assessment of intra-individual differences for the mtt, CBV, CBF, and BFI between the two hemispheres, the matched pair Wilcoxon sign rank test was used. The difference between CBF and BFI were also calculated and subjected to a matched pair Wilcoxon test. Furthermore, the Spearman's coefficient of correlation was determined between CBF and BFI values and the regression line has been calculated. Based on this correlation, BFI values have been transformed into cerebral blood flow values (CBF BFI ). The Bland & Altman [15] method was used to assess the agreement between the two kinds of CBF values. The bias, the precision of estimated limits of agreement and the relation between the differences and mean values were calculated. The statistical significance was determined on the 5% level.
Results
Measurements were performed bilaterally over both hemispheres at the forebrain of ten healthy volunteers in supine position. One data set had to be excluded from the post--processing due to artefacts induced by movements of the individuum in the OD signals. The hematocrit had been determined for women as 40.2 ±2.2% and for men as 47.2 ±3.2%.
The following results were obtained (Fig. 5) given as median (range), with mtt = 9.3 s (5.1-16.3 s), CBV = 3.5 ml/100 g (1.7-4.1 ml/100 g) and CBF = 18.2 ml/(100 g×min) (11.1-48.6 ml/100 g). Additionally, the median of BFI is BFI = 13.8 mg/s [6.2-15.2 mg/(100 g×s)].
Intra-individual comparisons
For further analysis paired values for mtt, CBV, and CBF of the left (l) and right (r) hemispheres in every individual were compared. The mean ±SD for the mtt for the right hemisphere in nine subjects was calculated to be mtt r = 9.9 ±3.6 s and for the left hemisphere mtt l = 9.8 ±2.7 s (p = 0.84), for the CBV CBV r = 3.3 ±0.8 ml/100 g and CBV l = 3. ±0.9 ml/100 g (p = 0.13) was obtained and for the CBF the results were CBF r = 23.2 ±12.8 ml/(100 g×min) and CBF l = 20.6 ±8.4 ml/(100 g×min) (p = 0.25). Likewise, for BFI, BFI r = 16.6 ±8.2 mg/s and BFI l = 13.8 ±4.5 mg/s (p = 0.20) was determined. For all values, no statistically significant differences between the two hemispheres could be detected.
Comparison of CB. and B.I
The Spearman's coefficient of correlation between CBF and BFI for the nine pair of bihemispheric measurements (n = 18) was calculated as R S = 0.76 (Fig. 6) . The correlation coefficient R 2 = 0.6 allowed the assumption that only 60% of the variability of the CBF could be described by the BFI. Finally, a matched pair Wilcoxon test to compare the CBF and BFI, showed that the mean values were different (p = 0.0025).
According to Kuebler , and based on the assumption that with the NIRS ICG dye dilution method mainly the blood flow within the grey and white matter is measured [25] , the BFI values were transformed into cerebral blood flow values, using the relation CBF BFI which was derived from the correlation between CBF and BFI. Following the Bland & Altman assessment, the differences between CBF NIRS and CBF BFI are presented against their mean values in Fig. 7 . The method is optimistic, however, because the bias is zero per definition, due to the fact that the CBF BFI is calculated using the regression line between BFI and CBF NIRS . Yet, the bias, estimated by the mean difference ±SD between the two CBFs, is 0 ±6.7 ml/(100 g×min). 94.5% of the data are within the limits of agreement, defined as the interval mean±2SD of differences (21.9 ±13.38 ml/(100 g×min). For example, when the calculated CBF BFI = 20 ml/(100 g×min) then the absolute cerebral blood flow can be in the range of 7-33 ml/(100 g×min) which is a rather wide range. Furthermore, the distribution of the differences is not symmetrically clustered around the mean, which allows the assumption that the BFI can be only seen as a trend value for the CBF.
Discussion
Prevention, detection and treatment of secondary ischemic events in patients with severe stroke and brain injury are major goals in neurointensive care. To this end, the balance between cerebral oxygen supply and consumption is a major parameter, but this can only be estimated if CBF is directly measured. Currently, the cerebral perfusion can be examined by perfusion computer tomography (CT), magnet resonance imaging (MRI) or positron emission tomography (PET) but this requires the use of stationary equipment and transportation of the patient. Especially transportation increases the risk that the patient suffers a secondary neurological deficit.
The newly developed NIRS ICG dye dilution method allows a non-invasive measurement of the parameters of cerebral hemodynamics directly at the bedside in the intensive care unit. However, no valid criteria exist at this time to enable an interpretation of the results for specific diseases, although the method has for example been applied in patients with acute ischemic stroke . An attempt was therefore made to define at first physiological critical threshold values for general use in neurointensive care.
In view of this goal, median values in nine healthy volunteers were determined with NIRS ICG dye dilution measurements. Results (median values with inter-individual range) were mtt = 9.3 s (5.1-16.3 s) , CBV = 3.5 ml/100 g (1.7-4.1 ml/10 g) and CBF = 18.2 ml/(100 g×min) [11.1-48.6 ml/(100 g×min)].
Our median values obtained with the NIRS ICG dye dilution technique for CBV are in good accordance with the results of PET studies [29] . In 2004, Ito [30] determined a mean CBV of 3.8 ±0.7 ml/100 g utilizing PET. Likewise, our calculated CBVs are comparable with values obtained in previous NIRS measurements [31, 32] , furthermore, in 2001, Van de Ven [33] determined a mean CBV of 3.66 ±0.82 ml/100 g with NIRS. Other studies, where the CBF has been determined, yielded values of 9-30 ml/(100 g×min) [34] and for children 6-19 ml/(100 g×min) [6] . Elwell determined the mean CBF with 11 ±4 ml/(100 g×min) [32] . These results were supported moreover by the mean (range) of CBF calculated using the impulse residue function (IRF), 8.3 ml/(100 g×min) [4.7-15.3 ml/(100 g×min)] or the modified Fick principle, 8.2 ml/(100 g×min) [4.2-6.2 ml/(100 g×min)] [16] .
Some discrepancy exists with respect to absolute CBF values obtained in SPECT studies [35, 36] or MRI measurements where significantly higher values were found. Yet, such measurements exhibit an enormous spread. According to the Kety-Schmidt [37] method, which is known as the Gold standard method to determine CBF without regional resolution, the CBF amounts to CBF KS = 54 ±12 ml/(100 g×min). Further absolute CBF values, calculated from SPECT measurements, were CBF SPECT = 22.2-54.5 ml/ (100 g×min) [35, 36] and in MRI examinations a value of CBF MRI = 225 ml/(100 g×min) [38] was found, which is by a factor of five times higher than our values.
There is no straightforward explanation for these differences, in particular in view of the large spread of the data. Of importance is, among other, the location of injection of the dye. In our procedure, the ICG is applied in the ante-cubital vein, which implies that the intermix between blood and the ICG tracer is stronger than in the case where ICG is injected central venously via a catheter. This can cause the rise time of the OD signal to be longer for the ante-cubital vein injection and the maximum of the OD signal to be smaller than in measurements with a central venous catheter injection. These circumstances can influence BFI and CBF measurements. A comparison study with respect to the influence of the injection point along with the dose seems to be necessary. Although it is quite common to use a body related dose with 0.5 mg/kg of ICG for the dilution method [1] , there are other approaches [17] .
The injection point will also effect the absolute BFI value, which we determined to be BFI = 13. 6.6, max = 15.2 mg/s). A correlation was found between BFI and CBF, although the absolute values are not comparable. It has already been noted that the BFI only describes a trend for the CBF. To investigate the influence of the location of injection on this correlation, further studies are necessary.
Following the approach of Kuebler, an investigation has been made to compare BFI and CBF values by determining the Spearman's coefficient of correlation. Based on this correlation BFI values have been transformed into cerebral blood flow values for the application of the human head. Finally, the two types of CBF values have been compared in a Bland & Altman statistic. On the one hand the method is per se excessively optimistic, because the bias is per definition zero. On the other hand the limits of agreement are rather wide, so that a CBF calculated from, e.g., a BFI = 20 will be in the range of 7-33 ml/(100 g×min), which includes the overall range of measured CBF values.
For the bihemispheric NIRS ICG dye dilution approach, there is no significant intra-individual difference between the two hemispheres for healthy volunteers, while in the case of acute stroke differences can be detected [1] . The fact that intraindivudually no significant differences in absolute values for CBV and CBF in the healthy volunteers are found supports the reproducibility of the measurement method and allows the conclusion that significant differences detected in patients over the hemispheres may reflect clinically relevant changes of regional cerebral perfusion. A significantly reduced CBF over one hemisphere might be indicative of the development of secondary ischaemia. Further technical developments are necessary such that from the OD signal analysis the oxygen extraction fraction (OEF) can be determined along with information on the metabolism within the optically observed territories.
Yet, there are some limitations of the NIRS ICG dilution method to be considered. The values of cerebral hemodynamics were obtained under the assumption of a fixed optical pathlength of DPF = 5.9 for 782 nm, a value which was obtained in previous Monte Carlo (MC) simulations of the photon paths . This DPF was also determined by others performing MC simulations on 3D anatomical head models based on MRI data. But, it has to be noted that the DPF does not respect possible individual differences of the volunteer heads, for which a spatially resolved NIRS approach would be necessary.
Another critical point in the discussion about quality and significance of CBF measurements obtained with the NIRS ICG dye method is the influence of extracerebral tissue [3] and the associated blood flow [26] . The present measurements were performed with a commercial NIRS system not having the option of depth-resolved NIRS with time of flight (TOF) distribution. Liebert et al. applied time-domain diffuse NIRS providing a robust depth-resolved analysis of absorption changes [41, 42] . The analysis is based on recorded distributions of TOF of photons diffusely reflected from the head after injecting picosecond laser pulses [41] . Moments of distributions of TOF of photons are analyzed to monitor the inflow and washout of a bolus of the dye ICG separately for different layers of the head [42] . To quantify differences in latency observed in different detection channels, corresponding to different positions of the optodes on the head as a function of time, the gamma-variate function was applied (analogous to the Gadolinium bolus used in perfusion weighted MRI) to analyze the first passage of ICG through the tissue and to estimate the mtt [42] . The authors performed measurements simultaneously over both hemispheres in healthy volunteers as well as in two patients with ischemic stroke, in one patient before and after recanalization of the occluded middle cerebral artery. In this patient a significant difference in bolus transit time between both hemispheres was observed which disappeared after one day. The authors conclude that a technique with sub-nanosecond time resolution to allow for depth discrimination is needed for clinical perfusion monitoring by optical methods. Liebert et al. encourage to establish time-resolved reflectance spectroscopy in clinical practice [42] . A potential limitation of the approach lies in its dependence on varying sensitivity factors for light absorption changes in the intracerebral and extracerebral tissue, which are not consistent with MC simulations [43] . Model assumptions such as the thickness of skin and skull or optical homogeneity of the tissue directly influence the algorithms for depth resolved NIRS [43] .
Nevertheless, in 1998, Kuebler has verified in a porcine model that BFI correlates with CBF and not with blood flow in the skin. On the basis of a human model, furthermore, where time of flight and frequency domain studies were made [27, 28] , it could be demonstrated that the ICG bolus appears first in the cerebral layer, while the ICG compartment within the extracerebral skin is smaller and delayed.
Additional confirmation has been provided with MC simulations, where the influence of blood volume within different tissues was taken into account. It could be shown that the influence of the extracerebral tissue during the first passage of the ICG dye can be assumed to be in the order of 20-30% of the entire OD signal [25] . Thereby, a positive circumstance in view of the clinical application of NIRS ICG dye dilution is that the relative blood volume for grey and white matter is higher than for the scalp and skull. This implies that 70-80% of the OD signal is measured from the tissue of interest, i.e., white and grey matter.
Limitations of measurement methods, concerning their measurement volume, furthermore, are to be considered. Jugular bulb oximetry is a global measurement method and its limitation has to be considered especially in patients with secondary focal ischemic events [44] . Small regions of ischemia imbedded within areas of normal or hyperemic flow may be missed applying global measurement methods using jugular bulb catheters. On the other hand, brain tissue oxygen tension pressure (PbtO 2 ) monitoring is suitable to detect focal changes in cerebral oxygenation pattern [45] . The technique, nevertheless, using intraparenchymatous brain catheters is an invasive method with a very small measurement volume of a few cubic millimeters, giving accurate results only if the probe is inserted directly into the area of interest. Own experiences in patients with SAH showed that cerebral vasospasm leading to focal ischemic events may occur in different and multiple vascular territories, presumably not being observed by a PbtO 2 -probe. In cases of distal arterial narrowing, techniques measuring regional values of local cortical perfusion, representing selected vascular territories, may be more sensitive. NIRS, observing an optical segment in the range of centimetres and being non invasive, may have the ideal measurement volume to monitor regional cerebral perfusion and oxygen metabolism in different vascular territories.
To summarize, the non-invasive NIRS ICG dye dilution method is a useful tool to detect cerebral hemodynamics non-invasively at the bedside. Own studies in patients with subarachnoid hemorrhage before and after treatment of cerebral vasospasm showed that the technique is safe and easy to perform in the clinical environment [46] . It could be shown by superselective papaverine infusion in vasospastic vessels measurements by NIRS seem to reflect changes from the intracerebral vessels. Further investigations in a larger set of patients are needed to evaluate its diagnostic accuracy in detection and treatment of cerebral vasospsm.
APPENDIX A
Using the 'black box' approach [22] for the cerebral system, the passage of ICG through the brain can be described by a convolution integral, containing an unknown transport function g(u)
A variety of transport functions are well accepted for medical model applications, e.g., the Log-norm distribution, Gamma-variant distribution, Lagged-density distribution or Local-density-random-walk-distribution [39] .
For the implementation of the current algorithm the Log-norm distribution by Stow & Hentzel [40] was used for g(t) with mtt being the t* appearing in the exponent, following the argumentation of Hoeft [39] [ ] 
The mtt now depends directly on the transport function and can be defined as 
In this assumption, the global mtt for the human head system can be approached by using the Log-norm function for g(t) and varying t* (mtt), until the determined ô(t) of the model given by Eq. (9) best matches the measured o(t) in the vena jugularis. The control is performed by checking that the sum of the square of the errors is minimal for o(t)-ô(t). The determined t* is the mtt of the system. However, for the non-invasive NIRS ICG dye dilution measurements, catheters are not used to measure directly i(t) and o(t), due to their invasive nature and the risk to the patient. Furthermore, regional cerebral blood flow is of more interest than global blood flow.
The transport function g(t) cannot be directly obtained. Instead the OD signal is monitored which depends mainly upon the concentration of the injected ICG dye as tracer within the illuminated tissue.
As Edwards [4] proposed, based on Fick's principle the total concentration of the tracer c ICGtotal at the time t in the optically examined segment is equal to the integrated difference between the inflow and outflow of the tracer substance ICG.
Consequently, the OD [Eq.
(1)] of the tissue containing ICG for the examined optical segment can be written as
OD(t 0 ) is the baseline signal of the OD signal depending on the chromophores of the extra-and intra-cerebral tissue. K is the unknown constant. The first derivative of Eq. (13) with respect to time is then written as
Again, the output flow of the optically observed segment can be determined by using a Lognorm function as transport function for the cerebral system and the convolution procedure of Eq. (9). 
Under the precondition that the transfer function is defined, this Eq. (15) can be used to determine i(t) and o(t) in 
Subsequently, the inflow is defined only in relation to the first derivative of the OD signal and the undefined constant K.
For a small time interval Ät the outflow becomes,
while the inflow is
This iteration process is continued until t is of the same order as the half-life period of ICG, approximately 5 min. The results are the inflow and the outflow of the optically observed segment, which are dependent on constant K'. As mentioned earlier the transport function g(u) is unknown, because t*, which is the mtt of the cerebral system, is missing. To solve this problem, an assumption can be made, that the mtt of the optically observed segment is in the range of 5-14 s as is known for the cerebral transit time for healthy volunteers [39] . So for a chosen t* in this range, i ICG (t) and o ICG (t) can be calculated and afterwards the results checked for plausibility. The variation of i ICG (t) and o ICG (t) are dependent upon t* (mtt) is shown in Figs. 8(a) and (b) .
The correct t*, meaning the mtt of the optically observed segment, is determined using the iterative process described above, checking its plausibility against i ICG (t) and o ICG (t). In this context, it must be taken into account that since ICG is applied as a bolus within 1-2 s, i ICG (t) is in reality completely dominated by the ICG. This effect is visible in the slope of i ICG (t) dropping to zero at the end of the first circulation.
Repeated measurements of NIRS ICG dye dilution have shown that i ICG (t) did not completely fall to zero. This observation can be explained by the fact that the blood flow in the capillaries of the scalp is slower than the blood flow in the cerebral capillaries. This implies that part of the ICG in the scalp affects the OD signal for longer. Consequently, a good approximation can be made when i ICG (t) decreased to 10% of the maximal blood volume before the first recirculation starts.
Opto-Electron. Rev., 16, no. 3, 2008 © 2008 SEP, Warsaw . For longer mtt, the more drastic is the decrease of i(t) and o(t) at the end of the first circulation. This is caused by the phenomenon that the o(t) starts late and the decreasing total concentration of blood can only be compensated with a negative inflow i(t). When mtt is chosen to be very small, i(t) and o(t) converge to the same outline.
